Original work

2024: 'Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe' (Carrick)
2022: 'Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in ARVC' (Gasperetti)
2022: 'Longitudinal prediction of ventricular arrhythmic risk in ARVC' (Te Riele)
2022: 'Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator' (Protonotarios)